×
The Standard e-Paper
Read Offline Anywhere
The Standard Group Plc is a
multi-media organization with investments in media platforms spanning newspaper
print operations, television, radio broadcasting, digital and online services. The
Standard Group is recognized as a leading multi-media house in Kenya with a key
influence in matters of national and international interest.
Kenya is among eight African countries that participated in clinical trials for a newly approved malaria treatment, specifically designed for newborns. Other participants, include Nigeria, the Democratic Republic of Congo, Burkina Faso, Mali, and Zambia.
The medicine, Coartem Baby (artemether‑lumefantrine), was approved by Swissmedic, Switzerland’s regulatory authority. This marks a significant milestone in the fight against malaria in infants, as it becomes the first treatment developed for use in newborns.
Subscribe to our newsletter and stay updated on the latest developments and special offers!
join